{"id":18791,"date":"2021-10-26T15:08:44","date_gmt":"2021-10-26T15:08:44","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=81271"},"modified":"2021-10-26T15:08:44","modified_gmt":"2021-10-26T15:08:44","slug":"trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process","status":"publish","type":"post","link":"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/","title":{"rendered":"TrialScope Atlas Helps Sponsors Reduce Risk, Manage the Complicated Global Clinical Trial Disclosure Process"},"content":{"rendered":"<div>\n<h4 align=\"center\">Dashboard automates disclosure, monitors compliance,\u00a0consolidates global regulations and corporate transparency policies<\/h4>\n<p align=\"left\">NEW YORK, Oct. 26, 2021 (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.google.com\/url?q=https:\/\/www.globenewswire.com\/Tracker?data%3DeypfDC2cQQV80QSr5_9Vc9N63PzAJ1e7wVr0bG9mlUEqZnbzmydVZS1fkzZdpNZ-Whx6PiFQ6I4An3D48hr6V7Il03DYCX9o_2AwU_RQvspt6_hi9psqghlzslO235Y_&amp;source=gmail-html&amp;ust=1635347309004000&amp;usg=AFQjCNEucDkJD0d6kEPNGcPp9hIgE-CGjQ\"  rel=\"nofollow noreferrer\">Informa Pharma Intelligence<\/a>, the global business intelligence provider for the biopharma industry, has launched <a href=\"https:\/\/www.google.com\/url?q=https:\/\/www.globenewswire.com\/Tracker?data%3D_k50BMuEv6MmIGuUY0Nh-jv7PWqE2cbA17GmYxW4feljnlZb3LAVnElZsDZzf0qsdm1CdHk1QtFWwukE-GfuT86cPm9iwDX40I97Z-UamatZfYYJAOrDQkkUW7cy_mo8Y0iTvBkH2dGPoplgM1_FqouWd9A5Mr4AM44u-PTMxlE%3D&amp;source=gmail-html&amp;ust=1635347309005000&amp;usg=AFQjCNE5IaeJYR-3z77jQ9__JjZ9mmgz6g\"  rel=\"nofollow noreferrer\">TrialScope Atlas<\/a>, a single, searchable dashboard that automates clinical trial disclosure and consolidates a concise set of relevant regulations.<\/p>\n<p>Clinical trial sponsors are under increased pressure to maintain regulatory disclosure compliance, for several reasons:<\/p>\n<ul type=\"disc\">\n<li>The EU CTIS clinical trial disclosure portal is scheduled to launch in January, bringing with it new regulations for study registration.<\/li>\n<li>Failure to disclose required information to ClinicalTrials.gov, under the auspices of the US National Institutes of Health, can result in fines of over $12,000 per trial per day.<\/li>\n<li>Lack of transparency leads to public mistrust and negative brand reputation.<\/li>\n<li>Potential investors are likely to walk away from deals involving noncompliant companies.<\/li>\n<\/ul>\n<p>However, no global standards exist for the scope and timing of disparate global disclosure requirements. With dozens of regulatory agencies worldwide and hundreds of disclosure regulations, sponsors are faced with the insurmountable challenge of keeping on top of changing regulatory requirements. In addition, global regulatory teams are often disjointed, separated by geography and time zones.<\/p>\n<p>TrialScope Atlas offers a centralized dashboard, uniting regulations as well as users. A robust compliance engine, backed by years of TrialScope\u2019s industry-leading disclosure experience, powers the platform. Disclosure experts monitor and analyze global disclosure regulations, removing the burden from sponsors. When users enter their study data into the platform, they receive automated notifications of what information needs to be disclosed, when it needs to be disclosed, and to which registries.<\/p>\n<p>\u201cGlobal clinical trial disclosure compliance is at a key turning point,\u201d said Denise Peterson, Editor-in-Chief of Pink Sheet, the Informa Pharma Intelligence publication providing regulatory and policy insights. \u201cThe US FDA has recently sent warning notifications to clinical trial sponsors, who could face fines over $12,000 per day for disclosure noncompliance. And in January 2022, the EU will be launching its new trials portal and Clinical Trials Regulations, which is expected to kick off compliance inspections in EU member countries. Now, more than ever, study sponsors must take disclosure compliance seriously.\u201d<\/p>\n<p>For more information, on TrialScope Atlas, visit <a href=\"https:\/\/www.google.com\/url?q=https:\/\/www.globenewswire.com\/Tracker?data%3DeypfDC2cQQV80QSr5_9Vc9N63PzAJ1e7wVr0bG9mlUG7qcWvvMGIANm-adOhMi9TR1t6c_yMrYuwnP63PDYauFJGzRLOtRLwsPvS_gfpppbkgVcLU83DAVIgQu7c-ygt&amp;source=gmail-html&amp;ust=1635347309005000&amp;usg=AFQjCNG_K28zyFwjy7guEgkZac8Mnj7y7Q\"  rel=\"nofollow noreferrer\">Informa Pharma Intelligence<\/a> or contact <a href=\"https:\/\/www.google.com\/url?q=https:\/\/www.globenewswire.com\/Tracker?data%3DMEGUk77frVnuGukAZf0_Uwh0bX1iRexD88Pm26R6NGimoNwPrQ3shKH8SB3rK6G7-t7ys1WX1hE5hRIK54CjxbJiXAkCtUDlmxjnoEnJdso%3D&amp;source=gmail-html&amp;ust=1635347309005000&amp;usg=AFQjCNFPsq0thGfIjm6c1xuZhTjAg0WjeA\"  rel=\"nofollow noreferrer\">pharma@informa.com<\/a>.<\/p>\n<p><strong>About Informa Pharma Intelligence<\/strong><br \/>\nInforma Pharma Intelligence powers a full suite of analysis products \u2013 Datamonitor Healthcare\u2122, Sitetrove\u2122, Trialtrove\u2122, Pharmaprojects\u2122, Biomedtracker\u2122, Scrip\u2122, Pink Sheet\u2122 and In Vivo\u2122 \u2013 to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.<\/p>\n<p>With more than 400 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&amp;D project isn\u2019t covered through the breadth and depth of data available to customers. For more information, visit <a href=\"https:\/\/www.google.com\/url?q=https:\/\/www.globenewswire.com\/Tracker?data%3DMEGUk77frVnuGukAZf0_U-5DlT0ARN70Ra3zpKC8QW1NyhQwUYTKcydBYoyxx-sHSlPg9aVPH9nPVz4lPS8Qk43H3Ebr_CGHm0AtElV1qq0TwUuyt2Wp2F_KuDIhuoag&amp;source=gmail-html&amp;ust=1635347309005000&amp;usg=AFQjCNFDyBhFEMp3VV4Ma1WXdCsLXXzz5w\"  rel=\"nofollow noreferrer\">pharmaintelligence.informa.com<\/a><\/p>\n<p><strong>Informa Pharma Intelligence PR Contact<\/strong><br \/>\nDiffusion PR for Informa Pharma Intelligence<br \/>\n<a href=\"https:\/\/www.google.com\/url?q=https:\/\/www.globenewswire.com\/Tracker?data%3DKbN5zwEFHWGFbvwr6UV8AFvwzC-9Mlb8m4NRGMGhk6DiKv5iva7xQ96ntj-tCQWtcPCWSBhWRSP4_ILoq-EGBtGk9SkAKetSqyJe3_rGPVjDCWf_HpS-BjuTu1ofnv4G&amp;source=gmail-html&amp;ust=1635347309005000&amp;usg=AFQjCNHbF_3zYYM7TY8WvbbuByr7_8bcCg\"  rel=\"nofollow noreferrer\">informapharma@diffusionpr.com<\/a><br \/>\n(213) 318-4500<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dashboard automates disclosure, monitors compliance,\u00a0consolidates global regulations and corporate transparency policies NEW YORK, Oct. 26, 2021 (GLOBE NEWSWIRE) \u2014 Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, has launched TrialScope Atlas, a single, searchable dashboard that automates clinical trial disclosure and consolidates a concise set of relevant regulations. Clinical trial sponsors [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>TrialScope Atlas Helps Sponsors Reduce Risk, Manage the Complicated Global Clinical Trial Disclosure Process - Myanmar Newswire<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TrialScope Atlas Helps Sponsors Reduce Risk, Manage the Complicated Global Clinical Trial Disclosure Process - Myanmar Newswire\" \/>\n<meta property=\"og:description\" content=\"Dashboard automates disclosure, monitors compliance,\u00a0consolidates global regulations and corporate transparency policies NEW YORK, Oct. 26, 2021 (GLOBE NEWSWIRE) \u2014 Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, has launched TrialScope Atlas, a single, searchable dashboard that automates clinical trial disclosure and consolidates a concise set of relevant regulations. Clinical trial sponsors [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/\" \/>\n<meta property=\"og:site_name\" content=\"Myanmar Newswire\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-26T15:08:44+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/myanmarnewswire.com\/#\/schema\/person\/f449613780cb879df549f28a5d10715b\"},\"headline\":\"TrialScope Atlas Helps Sponsors Reduce Risk, Manage the Complicated Global Clinical Trial Disclosure Process\",\"datePublished\":\"2021-10-26T15:08:44+00:00\",\"dateModified\":\"2021-10-26T15:08:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/\"},\"wordCount\":487,\"publisher\":{\"@id\":\"https:\/\/myanmarnewswire.com\/#organization\"},\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/\",\"url\":\"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/\",\"name\":\"TrialScope Atlas Helps Sponsors Reduce Risk, Manage the Complicated Global Clinical Trial Disclosure Process - Myanmar Newswire\",\"isPartOf\":{\"@id\":\"https:\/\/myanmarnewswire.com\/#website\"},\"datePublished\":\"2021-10-26T15:08:44+00:00\",\"dateModified\":\"2021-10-26T15:08:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/myanmarnewswire.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Press Releases\",\"item\":\"https:\/\/myanmarnewswire.com\/category\/press-releases\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"TrialScope Atlas Helps Sponsors Reduce Risk, Manage the Complicated Global Clinical Trial Disclosure Process\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/myanmarnewswire.com\/#website\",\"url\":\"https:\/\/myanmarnewswire.com\/\",\"name\":\"Myanmar Newswire\",\"description\":\"Latest News, Right Away!\",\"publisher\":{\"@id\":\"https:\/\/myanmarnewswire.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/myanmarnewswire.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/myanmarnewswire.com\/#organization\",\"name\":\"Myanmar Newswire\",\"url\":\"https:\/\/myanmarnewswire.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/myanmarnewswire.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/myanmarnewswire.com\/wp-content\/uploads\/2017\/08\/logo-2.png\",\"contentUrl\":\"https:\/\/myanmarnewswire.com\/wp-content\/uploads\/2017\/08\/logo-2.png\",\"width\":400,\"height\":54,\"caption\":\"Myanmar Newswire\"},\"image\":{\"@id\":\"https:\/\/myanmarnewswire.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/myanmarnewswire.com\/#\/schema\/person\/f449613780cb879df549f28a5d10715b\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/myanmarnewswire.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/myanmarnewswire.com\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TrialScope Atlas Helps Sponsors Reduce Risk, Manage the Complicated Global Clinical Trial Disclosure Process - Myanmar Newswire","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/","og_locale":"en_US","og_type":"article","og_title":"TrialScope Atlas Helps Sponsors Reduce Risk, Manage the Complicated Global Clinical Trial Disclosure Process - Myanmar Newswire","og_description":"Dashboard automates disclosure, monitors compliance,\u00a0consolidates global regulations and corporate transparency policies NEW YORK, Oct. 26, 2021 (GLOBE NEWSWIRE) \u2014 Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, has launched TrialScope Atlas, a single, searchable dashboard that automates clinical trial disclosure and consolidates a concise set of relevant regulations. Clinical trial sponsors [\u2026]","og_url":"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/","og_site_name":"Myanmar Newswire","article_published_time":"2021-10-26T15:08:44+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/#article","isPartOf":{"@id":"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/"},"author":{"name":"admin","@id":"https:\/\/myanmarnewswire.com\/#\/schema\/person\/f449613780cb879df549f28a5d10715b"},"headline":"TrialScope Atlas Helps Sponsors Reduce Risk, Manage the Complicated Global Clinical Trial Disclosure Process","datePublished":"2021-10-26T15:08:44+00:00","dateModified":"2021-10-26T15:08:44+00:00","mainEntityOfPage":{"@id":"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/"},"wordCount":487,"publisher":{"@id":"https:\/\/myanmarnewswire.com\/#organization"},"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/","url":"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/","name":"TrialScope Atlas Helps Sponsors Reduce Risk, Manage the Complicated Global Clinical Trial Disclosure Process - Myanmar Newswire","isPartOf":{"@id":"https:\/\/myanmarnewswire.com\/#website"},"datePublished":"2021-10-26T15:08:44+00:00","dateModified":"2021-10-26T15:08:44+00:00","breadcrumb":{"@id":"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/myanmarnewswire.com\/trialscope-atlas-helps-sponsors-reduce-risk-manage-the-complicated-global-clinical-trial-disclosure-process\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/myanmarnewswire.com\/"},{"@type":"ListItem","position":2,"name":"Press Releases","item":"https:\/\/myanmarnewswire.com\/category\/press-releases\/"},{"@type":"ListItem","position":3,"name":"TrialScope Atlas Helps Sponsors Reduce Risk, Manage the Complicated Global Clinical Trial Disclosure Process"}]},{"@type":"WebSite","@id":"https:\/\/myanmarnewswire.com\/#website","url":"https:\/\/myanmarnewswire.com\/","name":"Myanmar Newswire","description":"Latest News, Right Away!","publisher":{"@id":"https:\/\/myanmarnewswire.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/myanmarnewswire.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/myanmarnewswire.com\/#organization","name":"Myanmar Newswire","url":"https:\/\/myanmarnewswire.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/myanmarnewswire.com\/#\/schema\/logo\/image\/","url":"https:\/\/myanmarnewswire.com\/wp-content\/uploads\/2017\/08\/logo-2.png","contentUrl":"https:\/\/myanmarnewswire.com\/wp-content\/uploads\/2017\/08\/logo-2.png","width":400,"height":54,"caption":"Myanmar Newswire"},"image":{"@id":"https:\/\/myanmarnewswire.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/myanmarnewswire.com\/#\/schema\/person\/f449613780cb879df549f28a5d10715b","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/myanmarnewswire.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/myanmarnewswire.com\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/posts\/18791"}],"collection":[{"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/comments?post=18791"}],"version-history":[{"count":0,"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/posts\/18791\/revisions"}],"wp:attachment":[{"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/media?parent=18791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/categories?post=18791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/tags?post=18791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}